| Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, ... Nature medicine 28 (1), 125-135, 2022 | 102 | 2022 |
| DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells J Chung, YE Maruvka, S Sudhaman, J Kelly, NJ Haradhvala, V Bianchi, ... Cancer discovery 11 (5), 1176-1191, 2021 | 70 | 2021 |
| Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes S Sudhaman, UB Muthane, M Behari, ST Govindappa, RC Juyal, ... Journal of medical genetics 53 (8), 559-566, 2016 | 48 | 2016 |
| Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism S Sudhaman, K Prasad, M Behari, UB Muthane, RC Juyal, BK Thelma Journal of Medical Genetics 53 (7), 450-456, 2016 | 47 | 2016 |
| VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians S Sudhaman, M Behari, ST Govindappa, UB Muthane, RC Juyal, ... Neurobiology of aging 34 (10), 2442. e1-2442. e3, 2013 | 36 | 2013 |
| Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition BB Campbell, MA Galati, SC Stone, AN Riemenschneider, M Edwards, ... Cancer discovery 11 (6), 1454-1467, 2021 | 32 | 2021 |
| Early onset Parkinson's disease due to DJ1 mutations: An Indian study MM Abbas, ST Govindappa, S Sudhaman, BK Thelma, RC Juyal, ... Parkinsonism & Related Disorders 32, 20-24, 2016 | 31 | 2016 |
| Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients Z Eroglu, S Krinshpun, E Kalashnikova, S Sudhaman, T Ozturk Topcu, ... Cancer 129 (11), 1723-1734, 2023 | 28 | 2023 |
| Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch repair deficiency A Das, U Tabori, LC Sambira Nahum, NB Collins, R Deyell, R Dvir, ... Clinical Cancer Research 29 (23), 4770-4783, 2023 | 24 | 2023 |
| Genomic microsatellite signatures identify germline mismatch repair deficiency and risk of cancer onset J Chung, L Negm, V Bianchi, L Stengs, A Das, ZA Liu, S Sudhaman, ... Journal of Clinical Oncology 41 (4), 766-777, 2023 | 23 | 2023 |
| Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade MA Galati, KP Hodel, MS Gams, S Sudhaman, T Bridge, WJ Zahurancik, ... Cancer research 80 (24), 5606-5618, 2020 | 21 | 2020 |
| Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer DD Lee, M Komosa, S Sudhaman, R Leão, CH Zhang, JD Apolonio, ... The Journal of Clinical Investigation 131 (21), 2021 | 18 | 2021 |
| Immune checkpoint inhibition as single therapy for synchronous cancers exhibiting hypermutation: an IRRDC study JJ Henderson, A Das, DA Morgenstern, S Sudhaman, V Bianchi, J Chung, ... JCO Precision Oncology 6, e2100286, 2022 | 16 | 2022 |
| Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium A Das, NR Fernandez, A Levine, V Bianchi, LK Stengs, J Chung, L Negm, ... Cancer discovery 14 (2), 258-273, 2024 | 13 | 2024 |
| Upfront adjuvant immunotherapy of replication repair–deficient pediatric glioblastoma with chemoradiation-sparing approach T Larkin, A Das, V Bianchi, S Sudhaman, J Chung, N Alsafwani, L Negm, ... JCO Precision Oncology 5, 1426-1431, 2021 | 12 | 2021 |
| Germline biallelic mismatch repair deficiency in childhood glioblastoma and implications for clinical management AK Mishra, RB Achari, L Zameer, G Achari, A Gehani, P Roy, ... Neurology India 70 (2), 772-774, 2022 | 11 | 2022 |
| B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency B Oshrine, N Grana, C Moore, J Nguyen, M Crenshaw, M Edwards, ... Blood Advances 3 (12), 1795-1798, 2019 | 8 | 2019 |
| Longitudinal detection of circulating tumor DNA in patients with advanced renal cell carcinoma. A Basu, R Kollipara, S Sudhaman, T Mahmood, N Pajak, C Carson, ... Journal of Clinical Oncology 41 (6_suppl), 715-715, 2023 | 7 | 2023 |
| ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy ES Lebow, N Shaverdian, JE Eichholz, LB Kratochvil, M McCune, ... Frontiers in Oncology 13, 1253629, 2023 | 6 | 2023 |
| Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours A Nabbi, P Beck, A Delaidelli, DA Oldridge, S Sudhaman, K Zhu, ... Genome medicine 15 (1), 67, 2023 | 6 | 2023 |
